AN2 Therapeutics Inc [NASDAQ: ANTX] traded at a high on Wednesday, posting a 22.64 gain after which it closed the day’ session at $1.30.
The results of the trading session contributed to over 5524247 shares changing hands. Over the past one week, the price volatility of AN2 Therapeutics Inc stands at 9.84% while the volatility over the past one month is 4.67%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ANTX stock reached $38.84 million, with 29.74 million shares outstanding and 21.41 million shares in the current float. Compared to the average trading volume of 376.74K shares, ANTX reached a trading volume of 5524247 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about AN2 Therapeutics Inc [ANTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ANTX shares is $2.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ANTX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for AN2 Therapeutics Inc shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on August 09, 2024. The new note on the price target was released on August 09, 2024, representing the official price target for AN2 Therapeutics Inc stock. Previously, the target price had yet another raise to $5, while Leerink Partners analysts kept a Outperform rating on ANTX stock.
The Average True Range (ATR) for AN2 Therapeutics Inc is set at 0.06 The Price to Book ratio for the last quarter was 0.44, with the Price to Cash per share for the same quarter was set at 3.13.
How has ANTX stock performed recently?
AN2 Therapeutics Inc [ANTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.71. With this latest performance, ANTX shares gained by 20.37% in over the last four-week period, additionally sinking by -38.68% over the last 6 months – not to mention a drop of -92.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ANTX stock in for the last two-week period is set at 76.15, with the RSI for the last a single of trading hit 82.90, and the three-weeks RSI is set at 67.29 for AN2 Therapeutics Inc [ANTX]. The present Moving Average for the last 50 days of trading for this stock 1.0633, while it was recorded at 1.0720 for the last single week of trading, and 2.3364 for the last 200 days.
AN2 Therapeutics Inc [ANTX]: Deeper insight into the fundamentals
AN2 Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.75 and a Current Ratio set at 9.75.
Insider trade positions for AN2 Therapeutics Inc [ANTX]
There are presently around $52.31%, or 66.75%% of ANTX stock, in the hands of institutional investors. The top three institutional holders of ANTX stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 5.55 million shares, which is approximately 18.6515%. OCTAGON CAPITAL ADVISORS LP, holding 3.22 million shares of the stock with an approximate value of $$6.92 million in ANTX stocks shares; and OCTAGON CAPITAL ADVISORS LP, currently with $$4.49 million in ANTX stock with ownership which is approximately 7.0183%.
